To view this email as a web page, click here.

SGO 2019: Maintenance Rucaparib Effective for All Age Groups in Ovarian Cancer, but Safety Questioned

The results of a post-hoc exploratory analysis of the phase III ARIEL3 trial were promising, but with some caveats.

A 52-Year-Old Woman With Splenomegaly

A 52-year-old woman presents with abdominal discomfort, which on physical examination revealed the presence of splenomegaly. A splenectomy is performed. What is your diagnosis?

IN CASE YOU MISSED IT

Role of the ALK Inhibitor AZD3463 in Sorafenib-Resistant Acute Myeloid Leukemia

Investigators evaluated whether AZD3463 can induce apoptosis in a dose-dependent manner in a subset of AML patients.

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.